These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37057854)

  • 21. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
    Noble S; Faulds D
    Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management.
    Khawaja F; Batista MV; El Haddad L; Chemaly RF
    Curr Opin Infect Dis; 2019 Dec; 32(6):565-574. PubMed ID: 31567572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison with recipients of solid organ transplants.
    Panagou E; Zakout G; Keshani J; Smith C; Irish D; Mackinnon S; Kottaridis P; Fielding A; Griffiths PD
    Transpl Infect Dis; 2016 Jun; 18(3):405-14. PubMed ID: 27061703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus Cell-mediated Immunity Assays in Pediatric Transplantation.
    Otto WR; Vora SB; Dulek DE
    J Pediatric Infect Dis Soc; 2024 Feb; 13(Supplement_1):S22-S30. PubMed ID: 38417088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
    Kusne S; Shapiro R; Fung J
    Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What's New: Updates on Cytomegalovirus in Solid Organ Transplantation.
    Stewart AG; Kotton CN
    Transplantation; 2024 Apr; 108(4):884-897. PubMed ID: 37899366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.
    Martín-Gandul C; Pérez-Romero P; Blanco-Lobo P; Benmarzouk-Hidalgo OJ; Sánchez M; Gentil MA; Bernal C; Sobrino JM; Rodríguez-Hernández MJ; Cordero E;
    Transpl Int; 2014 Oct; 27(10):1060-8. PubMed ID: 24964364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytomegalovirus infection after solid-organ transplantation, its risk factors, direct and indirect effects and prevention strategies].
    Varga M; Remport A; Czebe K; Péter A; Toronyi E; Sárváry E; Fehérvári I; Sulyok B; Járay J
    Orv Hetil; 2008 Mar; 149(12):551-8. PubMed ID: 18343771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives.
    Hodowanec AC; Pikis A; Komatsu TE; Sampson MR; Younis IR; O'Rear JJ; Singer ME
    J Clin Pharmacol; 2019 Jun; 59(6):784-798. PubMed ID: 30586161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
    Avery RK; Silveira FP; Benedict K; Cleveland AA; Kauffman CA; Schuster MG; Dubberke ER; Husain S; Paterson DL; Chiller T; Pappas P
    Transpl Infect Dis; 2018 Jun; 20(3):e12877. PubMed ID: 29512935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How we treat cytomegalovirus in hematopoietic cell transplant recipients.
    Boeckh M; Ljungman P
    Blood; 2009 Jun; 113(23):5711-9. PubMed ID: 19299333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients.
    Royston L; Royston E; Masouridi-Levrat S; Chalandon Y; Van Delden C; Neofytos D
    Immun Inflamm Dis; 2021 Sep; 9(3):771-776. PubMed ID: 33949798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021.
    Kotton CN; Torre-Cisneros J; ; Aguado JM; Alain S; Baldanti F; Baumann G; Boeken U; de la Calle M; Carbone J; Ciceri F; Comoli P; Couzi L; Danziger-Isakov L; Fernández-Ruiz M; Girmenia C; Grossi PA; Hirsch HH; Humar A; Kamar N; Kotton C; Ljungman P; Malagola M; Mira E; Mueller N; Sester M; Teng CJ; Torre-Cisneros J; Ussetti P; Westall G; Wolf D; Zamora M
    Transpl Infect Dis; 2022 Dec; 24(6):e13977. PubMed ID: 36271650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.
    Limaye AP
    Semin Respir Infect; 2002 Dec; 17(4):265-73. PubMed ID: 12497543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytomegalovirus infection in transplant recipients].
    Gondo H
    Nihon Rinsho; 1998 Jan; 56(1):173-8. PubMed ID: 9465685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of cytomegalovirus infection in solid organ transplantation.
    Kotton CN
    Nat Rev Nephrol; 2010 Dec; 6(12):711-21. PubMed ID: 20978468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and management of cytomegalovirus infection in solid-organ transplantation.
    Mwintshi K; Brennan DC
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):295-304. PubMed ID: 17402844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of cytomegalovirus infection after hematopoietic stem cell transplantation].
    Nishida T
    Rinsho Ketsueki; 2020; 61(9):1417-1423. PubMed ID: 33162544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
    Avery RK; Marty FM; Strasfeld L; Lee I; Arrieta A; Chou S; Tatarowicz W; Villano S
    Transpl Infect Dis; 2010 Dec; 12(6):489-96. PubMed ID: 20682012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of letermovir resistance in solid organ transplant recipients with ganciclovir resistant cytomegalovirus infection: A case series and review of the literature.
    Hofmann E; Sidler D; Dahdal S; Bittel P; Suter-Riniker F; Manuel O; Walti LN; Hirzel C
    Transpl Infect Dis; 2021 Jun; 23(3):e13515. PubMed ID: 33210830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.